247 related articles for article (PubMed ID: 24720376)
21. Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial.
Gilbert DG; Rabinovich NE; McDaniel JT
Psychopharmacology (Berl); 2020 May; 237(5):1507-1519. PubMed ID: 32034447
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use.
Pacek LR; Vandrey R; Dermody SS; Denlinger-Apte RL; Lemieux A; Tidey JW; McClernon FJ; Bangdiwala AS; Drobes DJ; al'Absi M; Strasser AA; Koopmeiners JS; Hatsukami DK; Donny EC
Drug Alcohol Depend; 2016 Oct; 167():228-32. PubMed ID: 27590743
[TBL] [Abstract][Full Text] [Related]
23. Cannabis Use Is Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse Among Adults in the United States.
Weinberger AH; Delnevo CD; Wyka K; Gbedemah M; Lee J; Copeland J; Goodwin RD
Nicotine Tob Res; 2020 Jul; 22(8):1404-1408. PubMed ID: 31112595
[TBL] [Abstract][Full Text] [Related]
24. Temporal associations linking alcohol and cannabis use to cigarette smoking in young adults engaged in a tobacco cessation and relapse monitoring study.
Walters KJ; Emery NN; Thrul J; Tomko RL; Gray KM; McClure EA
Addict Behav; 2024 Feb; 149():107902. PubMed ID: 37924584
[TBL] [Abstract][Full Text] [Related]
25. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.
Arout CA; Cooper ZD; Reed SC; Foltin RW; Comer SD; Levin FR; Haney M
Addict Biol; 2021 Jul; 26(4):e12993. PubMed ID: 33389797
[TBL] [Abstract][Full Text] [Related]
26. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status.
Haney M; Bedi G; Cooper ZD; Glass A; Vosburg SK; Comer SD; Foltin RW
Biol Psychiatry; 2013 Feb; 73(3):242-8. PubMed ID: 22939992
[TBL] [Abstract][Full Text] [Related]
27. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences.
McClure EA; Tomko RL; Salazar CA; Akbar SA; Squeglia LM; Herrmann E; Carpenter MJ; Peters EN
Exp Clin Psychopharmacol; 2019 Jun; 27(3):265-275. PubMed ID: 30556733
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders.
Heffner JL; Anthenelli RM; Adler CM; Strakowski SM; Beavers J; DelBello MP
Psychiatry Res; 2013 Dec; 210(3):857-62. PubMed ID: 23684537
[TBL] [Abstract][Full Text] [Related]
29. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.
Rabin RA; Ashare RL; Schnoll RA; Cinciripini PM; Hawk LW; Lerman C; Tyndale RF; George TP
Am J Addict; 2016 Jun; 25(4):291-6. PubMed ID: 27187893
[TBL] [Abstract][Full Text] [Related]
30. Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment.
Campbell BK; Le T; Kapiteni K; Gubner NR; Guydish J
J Subst Abuse Treat; 2020 Sep; 116():108064. PubMed ID: 32741500
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of a group cessation program for co-smokers of cannabis and tobacco.
Becker J; Haug S; Kraemer T; Schaub MP
Drug Alcohol Rev; 2015 Jul; 34(4):418-26. PubMed ID: 25676414
[TBL] [Abstract][Full Text] [Related]
32. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial.
Walters KJ; Baker NL; Tomko RL; Gray KM; Carpenter MJ; McClure EA
BMC Psychol; 2023 Jan; 11(1):25. PubMed ID: 36698194
[TBL] [Abstract][Full Text] [Related]
33. Young adults report increased pleasure from smoking cigarettes when drinking alcohol but not when using marijuana.
Gubner NR; Thrul J; Kelly OA; Ramo DE
Addict Res Theory; 2018; 26(1):71-76. PubMed ID: 29371859
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
[TBL] [Abstract][Full Text] [Related]
35. Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.
Hindocha C; Lawn W; Freeman TP; Curran HV
Psychopharmacology (Berl); 2017 Nov; 234(21):3153-3163. PubMed ID: 28733813
[TBL] [Abstract][Full Text] [Related]
36. Disentangling the effects of cannabis and cigarette smoking on impulsivity.
Round JT; Fozard TE; Harrison AA; Kolokotroni KZ
J Psychopharmacol; 2020 Sep; 34(9):955-968. PubMed ID: 32519578
[TBL] [Abstract][Full Text] [Related]
37. Adding tobacco to cannabis--its frequency and likely implications.
Bélanger RE; Akre C; Kuntsche E; Gmel G; Suris JC
Nicotine Tob Res; 2011 Aug; 13(8):746-50. PubMed ID: 21454910
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial.
Arancini L; Bortolasci CC; Dodd S; Dean OM; Berk M
Trials; 2019 Sep; 20(1):555. PubMed ID: 31500670
[TBL] [Abstract][Full Text] [Related]
39. Nicotine dependence predicts cannabis use disorder symptoms among adolescents and young adults.
Dierker L; Braymiller J; Rose J; Goodwin R; Selya A
Drug Alcohol Depend; 2018 Jun; 187():212-220. PubMed ID: 29680677
[TBL] [Abstract][Full Text] [Related]
40. Correlates of smoker identity among intermittent and light daily young adult smokers: Findings from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study.
Smith DM; O'Connor RJ; Collins RL; Hyland AJ; Kozlowski LT
Addict Behav; 2019 Nov; 98():106034. PubMed ID: 31301643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
